A spinnable coating capable of releasing metal species to a broth of living organisms in a controlled manner is an extremely interesting material for a number of biotechnological applications. Polymer/metal nanocomposites are a viable choice but very little is known about their biological properties. Here, a polymer based nanocomposite loading stabilized copper nanoparticles is proposed as a biostatic coating and systematic correlations between material properties and biological effects are established. Experimental proof of the nanocomposite capability to release metal species in a controlled manner and eventually to slow or even inhibit the growth of living organisms, such as fungi and other pathogenic microorganisms, are provided. The biostatic activity is correlated to the nanoparticle loading that controls the release of copper species, independently evaluated by means of electro-thermal atomic absorption spectroscopy. Insights into the understanding of the controlled releasing process, involving CuO dissolution through the nanoclusters stabilizing layer, are also proposed.

No abstract

No abstract

No abstract

Biosystems integration into an organic field-effect transistor (OFET) structure is achieved by spin coating phospholipid or protein layers between the gate dielectric and the organic semiconductor. An architecture directly interfacing supported biological layers to the OFET channel is proposed and, strikingly, both the electronic properties and the biointerlayer functionality are fully retained. The platform bench tests involved OFETs integrating phospholipids and bacteriorhodopsin exposed to 1-5% anesthetic doses that reveal drug-induced changes in the lipid membrane. This result challenges the current anesthetic action model relying on the so far provided evidence that doses much higher than clinically relevant ones (2.4%) do not alter lipid bilayers' structure significantly. Furthermore, a streptavidin embedding OFET shows label-free biotin electronic detection at 10 parts-per-trillion concentration level, reaching state-of-the-art fluorescent assay performances. These examples show how the proposed bioelectronic platform, besides resulting in extremely performing biosensors, can open insights into biologically relevant phenomena involving membrane weak interfacial modifications.organic electronics | analytical bioassay | electronic biodetection